Pereira Ana S, Coutinho Inês
Dermatology, Coimbra Hospital and University Center, Coimbra, PRT.
Cureus. 2023 Sep 22;15(9):e45791. doi: 10.7759/cureus.45791. eCollection 2023 Sep.
Metastatic Crohn's disease (MCD) is a rare cutaneous manifestation of Crohn's Disease (CD), defined as non-caseating, granulomatous skin lesions non-contiguous with the gastrointestinal (GI) tract. Most patients with MCD either have concomitant classic manifestations of CD or develop them within a few months to years. We report a case of MCD without known involvement of the GI tract, after more than three years from diagnosis. After failure or intolerance to several conventional treatments, including oral corticosteroids and azathioprine, adalimumab was initiated with a good response. Diagnosis of cutaneous CD is made by a combination of clinical and histopathological findings. Therapeutic options include topical, intralesional, and systemic corticosteroids as well as topical and systemic immunosuppressants and immunomodulators. Surgical excision may be considered for refractory cases.
转移性克罗恩病(MCD)是克罗恩病(CD)一种罕见的皮肤表现,定义为与胃肠道(GI)不连续的非干酪样肉芽肿性皮肤病变。大多数MCD患者要么伴有CD的典型表现,要么在数月至数年之内出现这些表现。我们报告一例诊断三年多后仍无胃肠道受累迹象的MCD病例。在对包括口服皮质类固醇和硫唑嘌呤在内的几种传统治疗方法无效或不耐受后,开始使用阿达木单抗治疗,效果良好。皮肤型CD的诊断需结合临床和组织病理学检查结果。治疗选择包括外用、皮损内注射和全身应用皮质类固醇,以及外用和全身应用免疫抑制剂和免疫调节剂。对于难治性病例可考虑手术切除。